Holen Sie sich die Stockscreener-App
17.54
6.00%
-1.12
Handel nachbörslich:
17.54
Schlusskurs vom Vortag:
$18.66
Offen:
$18.23
24-Stunden-Volumen:
262.80K
Relative Volume:
11.96
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-12.43%
1M Leistung:
-13.78%
6M Leistung:
-37.22%
1J Leistung:
-39.79%
1-Tages-Spanne:
$17.29
$18.23
1-Wochen-Bereich:
$17.29
$20.05
52-Wochen-Spanne:
$17.29
$31.65
Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) Company Profile
Firmenname
Virtus Lifesci Biotech Clinical Trials Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie BBC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BBC
Virtus Lifesci Biotech Clinical Trials Etf
|
17.54 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
274.84 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
559.39 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
561.90 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
221.75 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
468.92 | 124.43B | 0 | 0 | 0 | 0.00 |
Virtus Lifesci Biotech Clinical Trials Etf Aktie (BBC) Neueste Nachrichten
(BBC) Investment Analysis and Advice - news.stocktradersdaily.com
Wall Street Week Ahead - Seeking Alpha
(BBC) Technical Data - news.stocktradersdaily.com
Trend Tracker for (BBC) - news.stocktradersdaily.com
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
(BBC) Trading Signals - Stock Traders Daily
(BBC) Trading Advice - Stock Traders Daily
(BBC) Proactive Strategies - Stock Traders Daily
Learn to Evaluate (BBC) using the Charts - Stock Traders Daily
Stock Market Movers Today • Top Gainers & Losers - Benzinga
When (BBC) Moves Investors should Listen - Stock Traders Daily
(BBC) Long Term Investment Analysis - Stock Traders Daily
How to Take Advantage of moves in (BBC) - Stock Traders Daily
(BBC) Pivots Trading Plans and Risk Controls - Stock Traders Daily
The 5 Best Biotech ETFs of 2024 - TradingView
Capitulation in biotech is near, as well as a rally – Piper Sandler (NYSEARCA:XBI) - Seeking Alpha
Long Term Trading Analysis for (BBC) - Stock Traders Daily
FYC: Smart Or Speculative Small-Cap Growth ETF? (NASDAQ:FYC) - Seeking Alpha
The Great Rotation: Just Getting Started? - ETF Trends
Time for Healthcare ETFs? - Yahoo Finance
Investors Bought Up IWM, RSP Last Week - etf.com
SBIO, XBI, or BBP: Which is the Best Biotech ETF, According to Analysts? - TipRanks
Pharma Stocks Look Cheap. Here's One Way To Invest. - Barchart
9 Best Biotech ETFs for 2024 - MSN
This biotech ETF sees ‘breakout’ while U.S. small-cap technology stocks lag - MarketWatch
ALPS’ Biotech ETF SBIO Week’s Top Performer - Nasdaq
Innovation Reigns In 10 Best-Performing ETFs Of The Last 3 Months - FA-mag.com
Biotech ETFs Advance on Speculation of a Takeover Bid for Global Blood Therapeutics - ETF Trends
5 ETFs Riding High on the Biotech Comeback - Yahoo Finance
Best Performing ETFs For June 2022 - TheStreet
Biotech ETF Tops in June: 5 Stocks That Outperform - Yahoo Finance
Betting on Biotech Bear Market Expiration Date - ETF Trends
How to Pick a Biotech ETF - Investment U
Best & Worst Performing ETFs Of 2022 - Yahoo Finance
Biotech ETFs That Outperformed Last Week - Yahoo Finance
Biotech Ready to Participate in Healthcare Bullishness - Nasdaq
Drug Price Debate Might Not Hinder Biotech ETFs - ETFdb.com
Size Up SBIO Ahead of Biotech Rebound - ETF Trends
Finding Synergy With SPY - etf.com
Healthcare ETFs Surge on FDA Full-Vaccine Nod & Deal News - Zacks Investment Research
After AstraZeneca, Oxford Nanopore Might Be The Next UK COVID Winner - Investing.com
Want to Use ETFs to Play Biotech? Choose Wisely. - Barron's
Unless Sorrento Makes Solid Progress Soon, It Will Likely Go Below $5 - Nasdaq
A Healthcare ETF Review: Biotech Beckons under Biden - ETF Trends
Medical Breakthrough ETFs for More than Just COVID - ETF Database
For 2021 Upside, Bet on the SBIO Biotech ETF - ETF Trends
Top Tech ETFs Right Now - Benzinga
Biotech ETFs Soar on Gilead-Immunomedics Deal - Yahoo Finance
Betting on Biotech With Utility Beyond Covid-19 - ETF Trends
A Healthcare ETF Could Benefit From Index Reshuffling - ETF Trends
ETF of the Week: iShares MSCI China ETF (MCHI) - ETF Trends
Finanzdaten der Virtus Lifesci Biotech Clinical Trials Etf-Aktie (BBC)
Es liegen keine Finanzdaten für Virtus Lifesci Biotech Clinical Trials Etf (BBC) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
0.89%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):